INTUITIVE SURGICAL INDIA PRIVATE LIMITED

LogicFlo AI raised $2.7 million in seed funding led by Lightspeed to expand its AI agent platform across pharmaceutical, biotech, and medtech organizations globally.

ForSight Robotics completed a $125M Series B funding round led by Eclipse to accelerate development of the ORYOM Platform, the world's first robotic surgery system for cataract and other eye diseases.

Cornerstone Robotics raised over $70 million in Series C funding led by EQT to accelerate commercialization of its Sentire endoscopic surgical system and challenge established players like da Vinci.

The Trump administration has imposed significant tariffs, including a 125% levy on Chinese imports, creating disruptions in pharmaceutical supply chains and potentially increasing drug development costs.

Brain Navi, a neurosurgical robotics company, has initiated IPO counseling with First Securities Inc., marking a significant step toward entering the capital market.

• J&J has successfully performed the first gastric bypass surgeries using its OTTAVA robotic surgical system at Memorial Hermann-Texas Medical Center, marking a significant milestone in the system's development. • The OTTAVA system features a unique design with four arms built into the operating table, targeting multiple procedures in general surgery within the upper abdomen, including gastric bypass, gastric sleeve, and hiatal hernia repair. • Following completion of the clinical trial, J&J plans to submit the OTTAVA system for De Novo authorization to the FDA, aiming to compete with market leader Intuitive Surgical in the growing robotic surgery market.

Intuitive Surgical received FDA 510(k) clearance for the SureForm 45 stapler, marking the first stapler designed specifically for single-port robotic surgery in the United States.

• Johnson & Johnson's Monarch Quest software update received FDA 510(k) clearance, boosting computational power by 260% to improve accuracy in reaching suspicious lung nodules. • The enhanced robotic platform integrates Nvidia's AI technology and GE Healthcare's OEC 3D mobile imaging system to navigate complex patient airways for more precise early-stage lung cancer diagnosis. • This advancement addresses a critical need in lung cancer detection, as nearly half of early-stage lesions occur in peripheral lung areas that are difficult to access with traditional bronchoscopy methods.

• Medtronic is preparing to submit its Hugo surgical robot system for FDA authorization by March 2024, targeting initial approval for urology indications. • The company reports significant international growth for Hugo, with procedure volumes more than doubling year-over-year in existing markets. • Medtronic's surgical robotics expansion comes amid evolving competition in the soft tissue robotics market, where Intuitive Surgical maintains leadership with its da Vinci system.

Johnson & Johnson's MedTech division has received IDE approval for its Ottava robotic surgical system, allowing clinical trials in the U.S.